AJP - Regu Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Regul Integr Comp Physiol 286: R1085-R1092, 2004. First published January 29, 2004; doi:10.1152/ajpregu.00726.2003
0363-6119/04 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
286/6/R1085    most recent
00726.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Luodonpää, M.
Right arrow Articles by Ruskoaho, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Luodonpää, M.
Right arrow Articles by Ruskoaho, H.

NEUROHUMORAL CONTROL OF CIRCULATION AND HYPERTENSION

Adrenomedullin modulates hemodynamic and cardiac effects of angiotensin II in conscious rats

Marja Luodonpää,1 Hanna Leskinen,1 Mika Ilves,2 Olli Vuolteenaho,2 and Heikki Ruskoaho1

Departments of 1Pharmacology and Toxicology, and 2PhysiologyBiocenter Oulu, University of Oulu, 90014 Oulu, Finland

Submitted 22 December 2003 ; accepted in final form 26 January 2004

We examined whether adrenomedullin, a vasoactive peptide expressed in the heart, modulates the increase in blood pressure, changes in systolic and diastolic function, and left ventricular hypertrophy produced by long-term administration of ANG II or norepinephrine in rats. Subcutaneous administration of adrenomedullin (1.5 µg·kg–1·h–1) for 1 wk inhibited the ANG II-induced (33.3 µg·kg–1·h–1 sc) increase in mean arterial pressure by 67% (P < 0.001) but had no effect of norepinephrine-induced (300 µg·kg–1·h–1 sc) hypertension. Adrenomedullin enhanced the ANG II-induced improvement in systolic function, resulting in a further 9% increase (P < 0.01) in the left ventricular ejection fraction and 19% increase (P < 0.05) in the left ventricular fractional shortening measured by echocardiography, meanwhile norepinephrine-induced changes in systolic function were remained unaffected. Adrenomedullin had no effect on ANG II- or norepinephrine-induced left ventricular hypertrophy or expression of hypertrophy-associated genes, including contractile protein and natriuretic peptide genes. The present study shows that adrenomedullin selectively suppressed the increase in blood pressure and augmented the improvement of systolic function induced by ANG II. Because adrenomedullin had no effects on ANG II- and norepinephrine-induced left ventricular hypertrophy, circulating adrenomedullin appears to act mainly as a regulator of vascular tone and cardiac function.

catecholamines; hypertrophy; ventricular function


Address for reprint requests and other correspondence: H. Ruskoaho, Dept. of Pharmacology and Toxicology, Faculty of Medicine, Univ. of Oulu, PO Box 5000, 90014 Oulu, Finland (E-mail: heikki.ruskoaho{at}oulu.fi).






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.